Clinical Trial Update: A PET Exploration of the Mechanism of Action of Dopamine Beta-hydroxylase Inhibition in Cocaine Addicts [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating dopamine beta-hydroxylase inhibition for cocaine dependence was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Dependence

Drugs mentioned

• Dopamine beta-hydroxylase inhibitor (undisclosed)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cocaine Dependence | Phase 4 | Status: WITHDRAWN